Regionally (Paris), the firm is also ranked Tier 1 in Biotechnology & Life Sciences, Health Care Law and Regulatory Practice, as well as Tier 2 in Regulatory, Competition / Antitrust Law and Product Liability Litigation.

We’re proud and grateful for this recognition, a reflection of our team’s dedication, expertise, and the trust our clients and partners place in us. Intuity’s recognition as a leading firm in these innovative fields motivates us to push boundaries even further.

Congratulations to Christophe Hénin and the entire Intuity team for their diligent, relevant and consistent work !

Christophe Henin remains in Biotechnology and Life Sciences Practice, Competition, antitrust Law, and Health Care Law.

Many thanks to our peers and clients who place their trust in us.

Find on your listening platforms the first episode of this thrilling podcast, animated by Jean-Yves Mairé, in Moustic Audio Agency studio.

It is dedicated to Distilbène (Stilbestrol), a « miracle » hormone non-patented supposed to prevent miscarriage between 1950 and 1970, may have caused severe side effects, result in countless litigations in France and worldwide, some are still in progress.

Christophe Henin, a recognized expert in product liability applied to healthcare products, enlighten us with plenty of other experts, about the context and legal effects of these cases that have stirred public opinion.

Good listening !

Links :

Apple podcast : https://lnkd.in/eR3P7mKT
Spotify : https://lnkd.in/e5wnMvHj

And many others (Deezer, Amazon…)

• Compensation to victims of sodium valproate

• Production of presumptive evidence ? True but not automatic ! Focus on Article 4 of directive on defective products

• Date of stabilisation or date of knowledge of the damage…A purely French dilemma: what about the interpretation of Article 10 (1) of directive on defective products ?

• The ten-year rule vs phased legal action : in the expectation of a better insight on interpretation of Article 10 (2) of directive on defective products